Opinion
Video
Author(s):
A panel of experts on non–muscle invasive bladder cancer (NMIBC) discuss challenges associated with BCG shortages and the impact on treatment options and patients’ quality of life.
RETAIN-2 interim data promising for dose-dense MVAC plus nivolumab in MIBC
Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care
Disitamab vedotin plus toripalimab shows safety, efficacy in MIBC
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
Avelumab prolongs OS, PFS in advanced urothelial carcinoma irrespective of diabetes status
Real-world outcomes with nadofaragene point to safety, efficacy of NMIBC treatment